300 related articles for article (PubMed ID: 30848941)
41. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
Tang L; Dai F; Liu Y; Yu X; Huang C; Wang Y; Yao W
Pharmacol Res; 2018 Jul; 133():201-212. PubMed ID: 29791873
[TBL] [Abstract][Full Text] [Related]
42. Cannabinoid receptor 2 deletion deteriorates myocardial infarction through the down-regulation of AMPK-mTOR-p70S6K signaling-mediated autophagy.
Hu Y; Tao Y; Hu J
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30923227
[TBL] [Abstract][Full Text] [Related]
43. Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.
Yao L; Chandra S; Toque HA; Bhatta A; Rojas M; Caldwell RB; Caldwell RW
Cardiovasc Res; 2013 Mar; 97(3):509-19. PubMed ID: 23250919
[TBL] [Abstract][Full Text] [Related]
44. Rho kinase as a therapeutic target in cardiovascular disease.
Surma M; Wei L; Shi J
Future Cardiol; 2011 Sep; 7(5):657-71. PubMed ID: 21929346
[TBL] [Abstract][Full Text] [Related]
45. ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice.
Shi J; Zhang YW; Yang Y; Zhang L; Wei L
J Mol Cell Cardiol; 2010 Nov; 49(5):819-28. PubMed ID: 20709073
[TBL] [Abstract][Full Text] [Related]
46. Overlapping and unique roles played by ROCK1 and 2 in the modulation of coding and long noncoding RNA expression.
Zhou HM; Zhang JG; Zhang X; Fan GR; Liu GL; Li Q
BMC Genomics; 2019 May; 20(1):409. PubMed ID: 31117934
[TBL] [Abstract][Full Text] [Related]
47. Development of Rho-kinase inhibitors for cardiovascular medicine.
Shimokawa H; Rashid M
Trends Pharmacol Sci; 2007 Jun; 28(6):296-302. PubMed ID: 17482681
[TBL] [Abstract][Full Text] [Related]
48. Neuroprotection Mediated by Upregulation of Endothelial Nitric Oxide Synthase in Rho-Associated, Coiled-Coil-Containing Kinase 2 Deficient Mice.
Hiroi Y; Noma K; Kim HH; Sladojevic N; Tabit CE; Li Y; Soydan G; Salomone S; Moskowitz MA; Liao JK
Circ J; 2018 Mar; 82(4):1195-1204. PubMed ID: 29353861
[TBL] [Abstract][Full Text] [Related]
49. RhoA/rock signaling mediates peroxynitrite-induced functional impairment of Rat coronary vessels.
Sun Z; Wu X; Li W; Peng H; Shen X; Ma L; Liu H; Li H
BMC Cardiovasc Disord; 2016 Oct; 16(1):193. PubMed ID: 27724862
[TBL] [Abstract][Full Text] [Related]
50. Rho Kinases and Cardiac Remodeling.
Shimizu T; Liao JK
Circ J; 2016 Jun; 80(7):1491-8. PubMed ID: 27251065
[TBL] [Abstract][Full Text] [Related]
51. Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2).
Gong H; Zhou L; Khelfat L; Qiu G; Wang Y; Mao K; Chen W
Med Sci Monit; 2019 Apr; 25():3090-3099. PubMed ID: 31026254
[TBL] [Abstract][Full Text] [Related]
52. Vascular smooth muscle ROCK1 contributes to hypoxia-induced pulmonary hypertension development in mice.
Penumatsa KC; Singhal AA; Warburton RR; Bear MD; Bhedi CD; Nasirova S; Wilson JL; Qi G; Preston IR; Hill NS; Fanburg BL; Kim YB; Toksoz D
Biochem Biophys Res Commun; 2022 May; 604():137-143. PubMed ID: 35303680
[TBL] [Abstract][Full Text] [Related]
53. Rho-associated protein kinase isoforms stimulate proliferation of vascular smooth muscle cells through ERK and induction of cyclin D1 and PCNA.
Zhao Y; Lv M; Lin H; Cui Y; Wei X; Qin Y; Kohama K; Gao Y
Biochem Biophys Res Commun; 2013 Mar; 432(3):488-93. PubMed ID: 23402758
[TBL] [Abstract][Full Text] [Related]
54. Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy.
Hua Y; Zhang Y; Ceylan-Isik AF; Wold LE; Nunn JM; Ren J
Basic Res Cardiol; 2011 Nov; 106(6):1173-91. PubMed ID: 21901288
[TBL] [Abstract][Full Text] [Related]
55. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG
J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317
[TBL] [Abstract][Full Text] [Related]
56. Ginsenoside Rb1 inhibits autophagy through regulation of Rho/ROCK and PI3K/mTOR pathways in a pressure-overload heart failure rat model.
Yang T; Miao Y; Zhang T; Mu N; Ruan L; Duan J; Zhu Y; Zhang R
J Pharm Pharmacol; 2018 Jun; 70(6):830-838. PubMed ID: 29574918
[TBL] [Abstract][Full Text] [Related]
57. ROCK2/ras
Masre SF; Rath N; Olson MF; Greenhalgh DA
Oncogene; 2017 May; 36(18):2529-2542. PubMed ID: 27991921
[TBL] [Abstract][Full Text] [Related]
58. Targeting ROCK signaling in health, malignant and non-malignant diseases.
Shahbazi R; Baradaran B; Khordadmehr M; Safaei S; Baghbanzadeh A; Jigari F; Ezzati H
Immunol Lett; 2020 Mar; 219():15-26. PubMed ID: 31904392
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of ROCK1 and ROCK2 inhibits human laryngeal squamous cell carcinoma.
Zhang J; He X; Ma Y; Liu Y; Shi H; Guo W; Liu L
Int J Clin Exp Pathol; 2015; 8(1):244-51. PubMed ID: 25755711
[TBL] [Abstract][Full Text] [Related]
60. Noise-induced cochlear F-actin depolymerization is mediated via ROCK2/p-ERM signaling.
Han Y; Wang X; Chen J; Sha SH
J Neurochem; 2015 Jun; 133(5):617-28. PubMed ID: 25683353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
